A case of emetophobia responding to mirtazapine and propranolol treatment

dc.authorid0000-0002-8930-2261en_US
dc.authorid0000-0002-8848-4956en_US
dc.authorid0000-0002-3412-9879en_US
dc.authorid0000-0001-5207-6240en_US
dc.contributor.authorKöksal, Merve
dc.contributor.authorKoçak, Gökçe
dc.contributor.authorÖztürk, Yusuf
dc.contributor.authorTufan, Ali Evren
dc.date.accessioned2023-11-22T08:29:07Z
dc.date.available2023-11-22T08:29:07Z
dc.date.issued2022en_US
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractEmetophobia (“phobia of vomiting and nausea” or “Specific Phobia- Other [Vomiting]” in Diagnostic and statistical manual of mental disorders-Fifth Edition [DSM-5]) is characterized by impairing, chronic phobic avoidance of nausea/vomiting as well as inordinate cognitive and autonomic responses when avoidance is not possible.1,2 Patients may have elevated disgust sensitivity, a tendency to display gastrointestinal symptoms of anxiety as well as misinterpretation of those symptoms as catastrophic.2 Data on pharmacological management of emetophobia among adolescents is limited with only 2 cases benefiting from selective serotonin reuptake inhibitors (fluoxetine and sertraline) while adults may also benefit from benzodiazepines. 3-5 Patients may apply to various medical specialty clinics for treatment and this may delay diagnosis and management. Here; we aim to present an adolescent with emetophobia and its management by mirtazapine and propranolol.en_US
dc.identifier.citationKöksal, M., Koçak, G., Öztürk, Y., & Tufan, A. E. (2022). A Case of Emetophobia Responding to Mirtazapine and Propranolol Treatment. Journal of Neurogastroenterology and Motility, 28(4), 709-710.en_US
dc.identifier.doi10.5056/jnm22133
dc.identifier.endpage710en_US
dc.identifier.issn2093-0879
dc.identifier.issn2093-0887
dc.identifier.issue4en_US
dc.identifier.pmid36250377en_US
dc.identifier.scopus2-s2.0-85141550518en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage709en_US
dc.identifier.urihttp://dx.doi.org/10.5056/jnm22133
dc.identifier.urihttps://hdl.handle.net/20.500.12491/11870
dc.identifier.volume28en_US
dc.identifier.wosWOS:000877926500018en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorKöksal, Merve
dc.institutionauthorKoçak, Gökçe
dc.institutionauthorÖztürk, Yusuf
dc.institutionauthorTufan, Ali Evren
dc.language.isoenen_US
dc.publisherKorean Society of Neurogastroenterlogy and Motilityen_US
dc.relation.ispartofJournal of Neurogastroenterology and Motilityen_US
dc.relation.publicationcategoryEditöre Mektup - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEmetophobiaen_US
dc.subjectSerotoninen_US
dc.subjectPropranolol Treatmenten_US
dc.titleA case of emetophobia responding to mirtazapine and propranolol treatmenten_US
dc.typeLetteren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
merve-koksal.pdf
Boyut:
193.92 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: